Borde Shambhavi, Matosevic Sandro
Department of Industrial and Physical Pharmacy, Purdue University, West Lafayette, IN, USA.
Department of Industrial and Physical Pharmacy, Purdue University, West Lafayette, IN, USA; Center for Cancer Research, Purdue University, West Lafayette, IN, USA.
Trends Pharmacol Sci. 2023 Nov;44(11):832-848. doi: 10.1016/j.tips.2023.08.009. Epub 2023 Sep 26.
The adaptation of natural killer (NK) cells to conditions in the microenvironment of tumors is deeply affected by their metabolic activity, itself a result of nutrient availability and the metabolism of the cancer cells themselves. Elevated rates of glycolysis and lipid metabolism in cancers not only lead to the accumulation of immunosuppressive byproducts but also contribute to an environment of elevated concentrations of extracellular metabolites. This results in altered NK cell bioenergetics through changes in transcriptional and translational profiles, ultimately affecting their pharmacology and impairing NK cell responses. However, understanding the metabolic processes that drive alterations in immunological signaling on NK cells remains both difficult and vastly underexplored. We discuss the varied and complex drivers of NK cell metabolism in homeostasis and the tumor microenvironment (TME), challenges associated with their targetability, and unexplored therapeutic opportunities.
自然杀伤(NK)细胞对肿瘤微环境条件的适应深受其代谢活性的影响,而代谢活性本身又是营养物质可用性和癌细胞自身代谢的结果。癌症中糖酵解和脂质代谢速率的升高不仅会导致免疫抑制副产物的积累,还会促成细胞外代谢物浓度升高的环境。这会通过转录和翻译谱的变化导致NK细胞生物能量学改变,最终影响其药理学并损害NK细胞反应。然而,了解驱动NK细胞免疫信号改变的代谢过程仍然既困难又远未得到充分探索。我们讨论了在稳态和肿瘤微环境(TME)中NK细胞代谢的各种复杂驱动因素、与其靶向性相关的挑战以及未被探索的治疗机会。